You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Lavipharm Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for LAVIPHARM, and what generic and branded alternatives to LAVIPHARM drugs are available?

LAVIPHARM has two approved drugs.

Summary for Lavipharm

US Patents:	0
Tradenames:	7
Ingredients:	2
NDAs:	2

Drugs and US Patents for Lavipharm

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Lavipharm	CATAPRES-TTS-2	clonidine	SYSTEM;TRANSDERMAL	018891-002	Oct 10, 1984	AB	RX	Yes	No		⤷ Sign Up				⤷ Sign Up
Lavipharm Labs	FENTANYL-50	fentanyl	FILM, EXTENDED RELEASE;TRANSDERMAL	077051-002	Aug 4, 2006		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Lavipharm Labs	FENTANYL-75	fentanyl	FILM, EXTENDED RELEASE;TRANSDERMAL	077051-003	Aug 4, 2006		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Lavipharm	CATAPRES-TTS-3	clonidine	SYSTEM;TRANSDERMAL	018891-003	Oct 10, 1984	AB	RX	Yes	Yes		⤷ Sign Up				⤷ Sign Up
Lavipharm	CATAPRES-TTS-1	clonidine	SYSTEM;TRANSDERMAL	018891-001	Oct 10, 1984	AB	RX	Yes	No		⤷ Sign Up				⤷ Sign Up
Lavipharm Labs	FENTANYL-25	fentanyl	FILM, EXTENDED RELEASE;TRANSDERMAL	077051-001	Aug 4, 2006		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Lavipharm Labs	FENTANYL-100	fentanyl	FILM, EXTENDED RELEASE;TRANSDERMAL	077051-004	Aug 4, 2006		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Lavipharm

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Lavipharm	CATAPRES-TTS-1	clonidine	SYSTEM;TRANSDERMAL	018891-001	Oct 10, 1984	4,201,211	⤷ Sign Up
Lavipharm	CATAPRES-TTS-3	clonidine	SYSTEM;TRANSDERMAL	018891-003	Oct 10, 1984	3,996,934	⤷ Sign Up
Lavipharm	CATAPRES-TTS-1	clonidine	SYSTEM;TRANSDERMAL	018891-001	Oct 10, 1984	3,454,701	⤷ Sign Up
Lavipharm	CATAPRES-TTS-3	clonidine	SYSTEM;TRANSDERMAL	018891-003	Oct 10, 1984	4,559,222	⤷ Sign Up
Lavipharm	CATAPRES-TTS-3	clonidine	SYSTEM;TRANSDERMAL	018891-003	Oct 10, 1984	3,454,701	⤷ Sign Up
Lavipharm	CATAPRES-TTS-3	clonidine	SYSTEM;TRANSDERMAL	018891-003	Oct 10, 1984	4,060,084	⤷ Sign Up
Lavipharm	CATAPRES-TTS-2	clonidine	SYSTEM;TRANSDERMAL	018891-002	Oct 10, 1984	4,060,084	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.